Ocular Therapeutix Inc
OCUL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.53B
Close$
$-1.13
116.8% downside
Current Fair Value
116.8% downsideOvervalued by 116.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.53 Billion |
|---|---|
| Enterprise Value | $1.01 Billion |
| Earnings per Share | $-1.42 |
| Beta | 0.99 |
| Outstanding Shares | 224,952,428 |
Return
| Return on Equity | -57.97% |
|---|---|
| Return on Assets | -44.90% |
| Return on Invested Capital | -49.31% |
Valuation & Multiples
| P/E Ratio | -4.91 |
|---|---|
| PEG | -30.4 |
| Price to Sales | - |
| Price to Book Ratio | 3.37 |
| Enterprise Value to Revenue | 19.43 |
| Enterprise Value to EBIT | -3.3 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$-0.40
Consensus analyst estimateRevenue Estimate
$13.20 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.36
Consensus analyst estimateRevenue Estimate
$14.27 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 29.43% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.96%▼ 91.18% |
|---|---|
| Total Invested | $33.80M▼ 98.35% |
| Investors Holding | 51▼ 226.00% |
About Ocular Therapeutix Inc
CEO: Antony Mattessich
